Accelerate wound healing of acute and chronic wounds in patients with Diabetes: Experience from Mexico using supplementary haemoglobin spray.

Similar documents
Post-surgical wound management of pilonidal cysts by using a haemoglobin spray

Haemoglobin. Granulox: TOPICAL HAEMOGLOBIN

Evaluating the use of a topical haemoglobin spray as adjunctive therapy in non-healing chronic wounds a pilot study Liezl Naude

Oxygen is required for normal cellular

Effect of topical haemoglobin on healing in patients with venous leg ulcers

Sores That Will Not Heal

Effect of topical haemoglobin on venous leg ulcer healing

The concept of self-care is becoming more. Topical oxygen-haemoglobin use on sloughy wounds: positive patient outcomes and the promotion of self-care

Case Report Selection

CASE 1: TYPE-II DIABETIC FOOT ULCER

Topical Oxygen Wound Therapy (MEDICAID)

ULCERS 1/12/ million diabetics in the US (2012) Reamputation Rate 26.7% at 1 year 48.3% at 3 years 60.7% at 5 years

Nanogen Aktiv. Naz Wahab MD, FAAFP, FAPWCA Nexderma

Granulox Update on evidence and science

MANAGEMENT OF DIABETIC WOUNDS : HEALTH CLINIC SETTING DR NORLIZAH PAIDI FAMILY MEDICINE SPECIALIST KLINIK KESIHATAN BANDAR MAS KOTA TINGGI JOHOR

Topical antimicrobials (antiseptics) Iodine, Silver, Honey

o Venous edema o Stasis ulcers o Varicose veins (not including spider veins) o Lipodermatosclerosis

Lower Extremity Wound Evaluation and Treatment

P. P.2-7 P R A C T I C A L

PluroGel Burn and Wound Dressing Chicago. 23 May 2014

Evaluation of the Use of a Silver Collagen Amorphous Gel in the Healing of Post Surgical and Dehisced Lesions

Supporting healthcare professionals in taking control of the infection risk with ACTICOAT Flex TAKE CONTROL. of the infection risk in chronic wound

Hemostasis Inflammatory Phase Proliferative/rebuilding Phase Maturation Phase

Total Contact Cast System

Prontosan. Clean. Easy Wound Healing. Wound Cleansing

Diabetic Foot Ulcers. Alex Khan APRN ACNS-BC MSN CWCN CFCN WCN-C. Advanced Practice Nurse / Adult Clinical Nurse Specialist

POLYHEAL MICRO - INSTRUCTIONS FOR USE

Your guide to wound debridement and assessment. Michelle Greenwood. Lorraine Grothier. Lead Nurse, Tissue Viability, Walsall Healthcare NHS Trust

A new classification of the diabetic ischaemic foot promotes a modern approach to treatment. Michael Edmonds King s College Hospital London

Understanding compression bandages. Leg Ulcer Management Team Patient Information Leaflet

Determining Wound Diagnosis and Documentation Tips Job Aid

Topical haemoglobin spray for diabetic foot ulceration

JMSCR Vol 06 Issue 03 Page March 2018

Reality TV Managing patients in the real world. Wounds UK Harrogate 2009

Wound Classification. Overview

Your Wound Care Journey: A Passport to Success

Clinical Policy: EpiFix Wound Treatment

Disclosures. Outpatient NPWT Options Free up Hospital Beds, but Do They Work? Objectives. Clinically Effective: Does it Work?

NovoSorb BTM. A unique synthetic biodegradable wound scaffold. Regenerating tissue. Changing lives.

Assessment of clinical effectiveness of haemoglobin spray as adjunctive therapy in the treatment of sloughy wounds

Case 1. July 14, th week wound gel 3 cm x 2.5 cm = 7.5 cm². May 25, st wound gel on 290 days PI treatment 4 cm x 2.4 cm = 9.

WOUND CARE. By Laural Aiesi, RN, BSN Alina Kisiel RN, BSN Summit ElderCare

Will it heal? How to assess the probability of wound healing

2008 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. CPT Copyright 2007 American Medical Association

Advancing the science of wound bed preparation

Despite almost 50 years of clinical use, the

Patient Product Information

Venous Insufficiency Ulcers. Patient Assessment: Superficial varicosities. Evidence of healed ulcers. Dermatitis. Normal ABI.

Lower Extremity Venous Disease (LEVD)

Wound Jeopardy: Name That Wound Session 142 Saturday, September 10 th 2011

4-layer compression bandaging system (includes microbe binding wound contact layer) Latex-free, 4-layer compression bandaging system

The Practical Use of LIGASANO white in Plastic Surgery

Definitions and criteria

Prevention and Management of Leg Ulcers

Gangrene. Introduction Gangrene is the death of tissues in your body. It happens when a part of your body loses its blood supply.

Limb Threatening Acute Right Small Toe Diabetic Ulcer with Infected Bone and Ascending Infection Problem Day #0 Day #0

End Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema. Original Policy Date

Independent evaluation of BEMER physical vascular regulation therapy

Class IV Laser Therapy on a Non Healing Grade 2 Pressure Ulcer

Case study: A targeted approach to healing complex wounds using the geko device.

Introducing A Scientifically Engineered Dressing That Provides Superior Wound Healing

Velcro Compression Devices

Foam dressings have frequently

Appropriate Dressing Selection For Treating Wounds

CIRCULAT The solution for circulatory problems.

Beyond the Basics ImprovingYour Wound Care Knowledge. Berna Goldentyer RN, BSN, CWOCN Kathy Hugen RN, BSN, CWOCN

Skin Tear Management Guide South West Regional Wound Care Program Last Updated April 10,

Interesting Case Series. Skin Grafting in Pyoderma Gangrenosum

A Pilot Study of Oxygen Therapy for Acute Leg Ulcers

Wound Assessment Report

Silver Dressings. Sajida Khatri PrescQIPP Primary Care Lead.

HOW TO APPLY EFFECTIVE MULTILAYER COMPRESSION BANDAGING

VASCULAR WOUNDS PATHOPHYSIOLOGY AND MANAGEMENT

Wound Management in Urgent Care

End-Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema

New Guideline in venous ulcer treatment: dressing, medication, intervention

NPWT Case Series EXPERIENCES WITH INVIA MOTION. Precious life Progressive care. Invia Motion Negative Pressure Wound Therapy

Venous Leg Ulcers. Care for Patients in All Settings

Self Management with Compression

3M Tegaderm Matrix Matrix Dressing. Matrix. Your questions answered

Wound Management. E. Foy White-Chu, MD, CWSP

Surgical Wounds & Incisions

QUICK GUIDE SNAP THERAPY SYSTEM

Regenerative Tissue Matrix in Treatment of Wounds

First Coast Service Options (FCSO) Medicare Policy Primer

The Power of a Hydroconductive Wound Dressing with LevaFiber Technology

of gluconic acid lowers honey's ph and Dr. Abid Rashid

Figure 8. Shapiro Wilks Test for Normality at 13 weeks

Patient Care Information

Use of Non-Contact Low Frequency Ultrasound in Wound Care

Categorisation of Wound Care and Associated Products

Venous. Arterial. Neuropathic (e.g. diabetic foot ulcer) Describe Wound Types & Stages of. Pressure Ulcers. Identify Phases of Healing & Wound Care

The Georgetown Team Approach to Diabetic Limb Salvage: 2013

Case Study 2 - Mr J. Medical history

Dressings do not heal wounds properly selected dressings enhance the body s ability to heal the wound. Progression Towards Healing

THERAPIES. HAND IN HAND. Need safe and efficient infection prevention and management? 1 The Cutimed. Closing wounds. Together.

DRESSING SELECTION. Rebecca Aburn MN NP Candidate

Simple, gentle and affordable. *smith&nephew V1STA Negative Pressure Wound Therapy

Transmetatarsal amputation in an at-risk diabetic population: a retrospective study

Essity Internal. Taking the fear out of wound infection: conquering everyday issues

Transcription:

Accelerate wound healing of acute and chronic wounds in patients with Diabetes: Experience from Mexico using supplementary haemoglobin spray. Obdulia Lopez Lopez 1, Fredrik Elg 2 Peter Engels 3, 1 Universidad Juarez Autonomade Tabasco, Tabasco, Mexico, 2 infirsthealthcare Ltd, London, UK, 3 Bergisch Gladbach, Germany,. Introduction: Patients with diabetes frequently develop chronic wounds with a common problem in of insufficient supply of nutrients and oxygen to the affected tissue. But oxygen is an essential component of the wound-healing process. 1 Overall body function at the cellular level, including the prevention of bacterial activity, can use up to 90% of consumed oxygen in the body. 2 Several approaches are available to provide additional oxygen topically to the wound. One of the most recent developments is to facilitate oxygen diffusion at the wound by applying purified haemoglobin 3,4. Several reports treating different types of chronic wounds described an enhanced wound healing using topically applied haemoglobin. 5-7 Aim was to evaluate the usefulness of implementing haemoglobin spray in the treatment of severe wounds of patients with diabetes. Here we present 15 cases of patients with diabetes mellitus presenting either severe acute (trauma) or chronic wounds, all treated at a wound care centre in Tabasco, Mexico. Wound treatment: All cases were treated at the same wound care centre. All patients suffer from diabetes mellitus as primary disease. Wounds were thoroughly debrided (if required) and rinsed with an antimicrobial electrolyzed acid solution. Thereafter, the haemoglobin spray was administered as thin layer. A sterile paraffin gauze served as dressing. Frequency of dressing changes was initially three times per week or twice per week while reduced later to once weekly

Results Results: In total 15 patients (19 wounds) were analysed; Average baseline wound size was 46 cm 2 /41cm 3, and average treatment period was 91 days (14 weeks); Average of wound dressing changes was 16 (median 16), and 15 haemoglobin applications (median 14); Wound closure of 19 (out of 19) wounds in 15 patients; In 7 cases amputation was prevented; Average cost of material per patient and dressing change including haemoglobin spray was at 9.30; No adverse events related to the treatment with the haemoglobin spray were reported; Frequency of treatment was initially two to three times per week during the first days or weeks, and could be reduced to once weekly at later stage of wound healing. Case No. Age Gender Wound type Years M=male F=female 1 67 F 2 43 M 3 51 M 4 50 M 5 50 M Acute abscess/ Pressure ulcer, left Treatment period Days days cm 2 cm 3 No. of applications Costs per treatment 1 7 80 80 177 29 28 n yes* 7,52 Pressure ulcer 2 26 26 30 8 7 n yes n.d. Pressure ulcer 3 12,5 12,5 77 8 8 n yes n.d. DFU/after amputation, left Chronic venous leg ulcer, left leg 1 3 26,3 39,4 126 23 22 n yes 7,58 1 4 28 19 149 24 22 y yes 11,35 1 8 71 34 91 17 16 y yes n.d. 1 730 257 257 269 39 37 y yes 19,46 6 62 M Abscess, right leg 1 5 23 18,4 77 15 14 n yes 11,40 7 50 M 8 66 M 9 43 F 10 56 M 11 80 M Acute Trauma, left Wound after amputation of finger F-V, right hand leg Acute trauma, toe of right DFU/after amputation, left 1 15 42 42 112 22 21 y yes n.d. 1 3 115 69 98 22 21 y yes 11,71 1 20 10 3 112 18 18 n yes 7,12 1 30 6 18 42 10 9 y yes 7,40 1 30 36 3,6 72 14 13 n yes 7,38 12 78 M Abcess, right buttock 1 26 22,5 4,5 87 18 17 n yes 7,36 13 50 F DFU, right 1 25 45,5 22,7 89 16 13 y yes 6,83 14 50 F 15 75 F Median 51 5/10 (F/M) Wound healing disturbance, right buttock Abcess, right buttock Wound No. Wound Age Wound size No. of dressing changes Haemoglobi n spray Risk of Wound amputation closure 1 39 43,7 13,1 49 9 9 n yes 7,89 2 39 7,5 2,2 14 4 4 yes n.d. 3 39 1,2 0,4 7 2 2 yes n.d. 1 9 25 125 54 12 11 n yes 7,39 20,00 26,30 19,00 87,00 16,00 14,00 7,52 Average 58 60,7 46,2 41,6 91,2 16,3 15,4 9,26 Euro SD 12 167,8 56,8 59,4 59,7 8,8 8,4 3,41

Case No. 3 & 5 51 years old male patient Amputation prevented Fig. 1: Wound at A-C: Wound after cleansing & first application of Granulox, D - H: Wound after 16, 23, 37, 51, and 93 days; I: end of treatment (Day 149 ). Diagnosis: Diabetic. Wound caused by an injury was located on the dorsal dorsal and plantar surface of the first metatarsophalangeal joint of the right Underlying Conditions: 2 year history of uncontrolled diabetes. Diabetic neuropathy, chronic hypertension, chronic venous insufficiency and obesity. Patient Care: A comprehensive treatment protocol was applied, based on the result of the patient's overall assessment. Double antibiotic therapy prescribed to combat the infection, followed by prophylactic monotherapy, subject to kidney function values. Walking completely avoided for three weeks, then only relatively. Wound Care: Following surgical debridement, the wound was washed with diluted neutral soap, and rinsed with an antimicrobial solution (electrolysed acid solution). Haemoglobin spray was added first time at the second dressing change after rinsing. The wound was covered with sterile paraffin gauze to protect the granulation tissue. During the first two weeks the treatment including haemoglobin spray application was performed every three days, thereafter the dressing change including application of the haemoglobin spray was performed every eight days until the patient was discharged. Results: Complete wound healing was achieved within 149 days after 24 wound treatments and 23 applications of haemoglobin spray. Amputation could be avoided. In addition type 2 Diabetes Mellitus, chronic hypertension, and obesity were treated adequately. 50 years old female patient Planned amputation prevented Fig. 3: Wound at A& B) Wound before and after debridement, C) application of Granulox, D - G: Wound after 10, 45, 97, and 174 days; H: end of treatment (Day 279). Diagnosis: Extensive contaminated, complicated chronic venous ulcer affecting the outer and inner sides of the left leg from below the knee to above the ankle which developed over the last two years Underlying Conditions: Uncontrolled type 2 Diabetes Mellitus, chronic hypertension, peripheral venous insufficiency, obesity and depression. Patient Care: A comprehensive treatment protocol was applied, based on the result of the patient's overall assessment. Double antibiotic therapy prophylactic monotherapy, subject to kidney function values. Wound Care: After surgical debridement, the wound was washed with diluted neutral soap, and rinsed with an antimicrobial solution (electrolysed acid solution). Haemoglobin spray was added first time at the second dressing change after rinsing. The wound was covered with sterile paraffin gauze to protect the granulation tissue. During the first two months the treatment was performed every three days, thereafter the application of the haemoglobin spray was performed every eight days while twice a week dressings were changed by her family at home. Results: Complete wound closure of the more than 2 year old large lower leg wound could be achieved within 9 months. A planned amputation of the leg could be prevented.

Case No. 8 & 13 64 years old male patient Amputation prevented Fig. 2: Wound at A & B: Start after amputation and debridement before haemoglobin spray application C & D: day 5 (second application of haemoglobin spray), E & F: Day 28; G & H: Day 135 (21 applications of haemoglobin spray); Diagnosis: Wound on the palmar and dorsal surfaces of the right hand with amputation of the fifth finger subsequent to drainage, surgical debridement and amputation caused by an abscess resulting from a splinter injury. Underlying Conditions: Five-year history of uncontrolled type 2 Diabetes Mellitus and untreated Peripheral Venous Insufficiency. Patient Care: A comprehensive treatment protocol was applied, based on the result of the patient's overall assessment. Double antibiotic therapy prophylactic monotherapy, subject to kidney function values. Wound Care: Surgical debridement was performed at day one and again two days later to remove the remaining affected tissue from the wound. After debridement and/or cleansing, the wound was washed with diluted neutral soap, and rinsed with an antimicrobial rinsing solution. Haemoglobin spray was applied at the third dressing change (Day 3 of treatment). The wound was covered with sterile paraffin gauze to protect the granulation tissue, applying surgical dressings and a bandage without compression. The patient had daily dressing changes for the first three days, until the surgical debridement was completed and haemoglobin spray was applied for the first time. Next two weeks it was applied twice a week, then once per week. Results: After 22 treatments and 21 applications of haemoglobin spray the wound was almost healed within 5 months. 50 years old female patient Planned amputation prevented Fig. 4: Wound at A) Start of treatment after surgical debridement, B) second dressing change before application of haemoglobin spray, C) & D) tenth and eleventh dressing change (Day 47/ 54) E) Day 75 (fourteenth dressing change) and F) end of treatment; Diagnosis: Diabetic. Necrotic wound located on the dorsal surface of the right (secondary to atopic dermatitis). Underlying Conditions: Fifteen-year history of type 2 Diabetes mellitus and systemic hypertension, obesity (metabolic syndrome), and untreated peripheral venous insufficiency. Patient Care: A comprehensive treatment protocol was applied, based on the result of the patient's assessment. Treatment of associated metabolic diseases (type 2 Diabetes Mellitus, Chronic Hypertension) was modified, treatment was added for Peripheral Venous Insufficiency and Obesity. Double antibiotic therapy prophylactic monotherapy, subject to kidney function values. Patient had to avoid walking as much as possible. Wound Care: After surgical debridement, the wound was washed with diluted neutral soap, and rinsed with an antimicrobial rinsing solution (electrolysed acid solution). Haemoglobin spray was applied from the second dressing change after wound rinsing. The wound was covered with a sterile paraffin gauze to protect the granulation tissue and an adhesive protective dressing was applied. Results: Healing is complete within 2 months and 27 days, after 16 wound treatments and 15 applications of the haemoglobin spray.

Discussion Haemoglobin spray is an effective adjunctive therapy option for acute and chronic wounds in patients with diabetes, based on: Excellent tolerability: In all cases, the haemoglobin spray was well tolerated and no adverse effects were reported. Effective facilitation of healing at all stages: Can be applied during all wound healing phases in combination with most of the wound rinsing solutions and dressings Cost effective: Total costs for materials used per patients were 9,30 per dressing change ( 7.50 median) Early implementation of the haemoglobin spray in ulceration in diabetics may help prevent development of chronic wounds and / or amputation. Further studies are desirable to further evidence the beneficial effect of the haemoglobin spray in wounds at risk to develop a wound healing disturbance. Conclusion: Haemoglobin spray is an effective adjunctive therapy option for acute and chronic wounds in patients with diabetes to accelerate wound healing. References: 1) Sen, C.K. Wound Healing Essentials: Let there be oxygen. Wound Repair Regen 2009;17, 1-18. 2) Norris R, A topical haemoglobin spray for oxygenating chronic venous leg ulcers: a pilot study. 2014, Br J Nurs 23, S48-53; 3) Barnikol WK, et al.. Eine neue topische Behandlung chronischer Wunden mit Hämoglobin und Sauerstoff. ZfW 2005; 13: 98-108. 4)Petri, M., et al., Photoacoustic imaging of real-time oxygen changes in chronic leg ulcers after topical application of a haemoglobin spray: a pilot study. J Wound Care, 2016. 25(2): p. 87-91.; 5) Chadwick P Pilot study: haemoglobin spray in the treatment of chronic diabetic ulcers. Wounds UK 2014, 10: 76-80 6) Tickle J. A topical haemoglobin spray for oxygenating pressure ulcers: a pilot study. Br J Community Nurs. 2015; Suppl Wound Care: S12, S14-18. 7) Arenberger, P. et al. Clinical results of the application of a hemoglobin spray to promote healing of chronic wounds. GMS Krankenhaushyg Interdiszip. 2011; 6